We look into the drug interactions by gender and age. To complete a visual compatibility study of iv pantoprazole with 17 other iv medications, as well as with a mixture of 3. Detailed compatibility tables for each drug covering solution, additive, syringe, and ysite. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Breakage of pantoprazole vials reported during attempts to connect the vials to spiked iv system adapters. Octreotide bcca cancer drug manual page 6 of 9 octreotide developed. Octreotide has been recommended for the management of hypoglycemia induced by sulfonylureas. The related drug information index provides comprehensive access to all drug information related to a specific drug types of content include full prescribing information, drug summaries, full prescribing information continuing medication education full pi cme, medication guides, risk evaluation and mitigation strategies rems summaries, rems continuing medication. Sandostatin lar summary of product characteristics smpc. Pantoprazole solutions were physically compatible with 12 of the 17 drugs tested and with the mixture of 3. Patients receiving iv pantoprazole often require concomitant iv drugs and solutions. What conditions does octreotide acetate vial treat. It is a clear liquid that is usually injected under the skin daily injection or. The nola nets group uses thisothers use lesscant speak to their results but even with these higher than others type dosing we have had 2 carcinoid crisis out of about 300 or visits two hours before surgery give 500 micrograms of octreotide acetate iv.
Proton pump inhibitors ppi pantoprazole 40mg iv q12h should be administered to decrease the incidence of rebleeding for up to 72 hours. Octreotide is known chemically as lcysteinamide, dphenylalanyllcysteinyllphenylalanyldtryptophyl. In addition, octreotide has also been consistently associated with a decreased need for transfusions. For solution and drug compatibility information, see compatibility under. Continuous infusion of pantoprazole with octreotide does. Octreotide has been used safely in patients without serious cardiovascular disease. In a randomized controlled trial of 50 ml of 50% dextrose intravenously, oral carbohydrate with 50 ml of 50% dextrose and oral carbohydrate plus subcutaneous octreotide. These substances may be made in excessive amounts by the body because of certain conditions like tumors. The stability of the compound in aqueous solution is phdependent. Octreotide is a drug used to treat diarrhea and skin flushing caused by certain types of cancer. Octreotide is a synthetic longacting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. This ed material has been downloaded from a licensed data provider and is not for distribution, except.
Pantoprazole sodium is freely soluble in water, very slightly soluble in phosphate buffer at ph 7. Octreotide belongs to a class of drugs called octapeptides, which work by decreasing the amounts of certain natural substances. Do not confuse protonix pantoprazole with lotronex alosetron or protamine. The pharmacokinetic profile of octreotide after injection of sandostatin lar reflects the release profile from the polymer matrix and its biodegradation. Octreotide is hormone drug that is used to treat some types of cancer. In this setting, in the absence of endoscopy, intensivists generally provide supportive care transfusion of blood products and acid suppression such as proton pump inhibitors. Pantoprazole sodium is a white to offwhite crystalline powder and is racemic. Drug interactions are reported among people who take pantoprazole sodium and octreotide acetate together. Octreotide brand name sandostatin, among others is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Octreotide lowers many substances in the body such as insulin and glucagon involved in regulating blood sugar, growth hormone, and chemicals that affect digestion octreotide is used to treat acromegaly.
Octreotide lowers many substances in the body such as insulin and glucagon involved in regulating blood sugar, growth hormone, and chemicals that affect digestion. Avoid abrupt withdrawal of shortacting subcutaneous octreotide associated with biliary colic and pancreatitis. Pantoprazole has weakly basic and acidic properties. Once released into the systemic circulation, octreotide distributes according to its known pharmacokinetic properties, as described for s. Seventeen drugs, each at 3 different concentrations prepared in 5% dextrose in water d5w for injection. The drug is also prescribed for acromegaly a condition in.
Methods preparation of test mixtures of drugs seventeen drugs detailed in table 1, each diluted. Closely follow mixing instructions included in the packaging. Patients should be continued on oral ppi therapy pantoprazole 40mg po q24h duration dependent on indication. This study is created by ehealthme based on reports of 45 people who take pantoprazole sodium and octreotide acetate from the food and drug administration fda, and is updated regularly. Delayedrelease tablets should be swallowed whole without regard to meals or.
This medicine is given to control symptoms such as diarrhea or flushing in patients with tumors such as carcinoid. Octreotide is also used to reduce flushing episodes and watery diarrhea. Learn vocabulary, terms, and more with flashcards, games, and other study tools. Octreotide has been shown to be at least as effective as vasopressin in the treatment of bleeding varices, with fewer and less severe systemic adverse effects. Pantoprazole and esomeprazole are the only intravenous formulations available in the united states, and intravenous management and prognosis of the zollingerellison syndrome gastrinoma view in chinese. To complete a visual compatibility study of iv pantoprazole with 17 other iv. After reconstitution, dilute dose to a final volume of 50mls with compatible infusion fluid and administer over at least 30 minutes. Administer immediaterelease shortacting injection subq or iv, as a rapid iv injection 1 2 3 or as an iv infusion. Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhage article in pharmacotherapy 293.
Diarrhea, abdominal cramping, fever, and bloody stools should be reported to health care professional promptly as a sign of pseudomembranous colitis. Iv drug compatibility chart g ganciclovir sodium gemcitabine hydrochloride gemtuzumab ozogamicin gentamicin sulfate granisetron hydrochloride. The injection form of this drug is used for a short time when you cannot take the medication by mouth. Novartis international package leaflet template, office97 version. Maintenance2575 mcgkgmin infusion or incremental bolusesof1020mg. For more detail, see how this drug works section below. Request pdf physical compatibility of pantoprazole with selected medications. Current guidelines recommend highdose continuous infusion ppis e. On april 24, 2020, the us fda approved menquadfitm meningococcal vaccine, tetanus toxoid conjugate quadrivalent im injection indicated for active immunization for the prevention of invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y in individuals 2 years of age and older.
However, two recent trials and two metaanalyses have demonstrated no difference in efficacy with lowdose therapy e. It is a longacting octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. By continuing to browse this site you are agreeing to our use of cookies. Octreotide is available in an injectable form to be given directly into a vein iv by a healthcare professional. This information is intended for use by health professionals. There can be variation in the licensing of different medicines containing the.
Pantoprazole 20 mg tablets can be sold to the public for the shortterm treatment of reflux symptoms e. Octreotide acetate injection is stable in sterile isotonic saline solutions or sterile solutions of dextrose 5% in water for 24 hours. Route onset peak duration pantoprazole pantoeprazole. Octreotide 100 to 200 mcg subcutaneously 3 times daily in combination with midodrine range. A complete description of octreotide benefits, dosage form, indications, antidote effects against antidote for sulfonylureainduced hypoglycemias, use for n. Pantoprazole belongs to a class of drugs known as proton pump inhibitors ppis. Whether it is the primary reason for admission or a complication of critical illness, upper gastrointestinal bleeding is commonly encountered in the intensive care unit.
Dailymed sandostatin lar depot octreotide acetate kit. Octreotide is the acetate salt of a cyclic octapeptide. Octreotide acetate pharmacokinetics absorption bioavailability. Selected from data included with permission and ed by first databank, inc. Octreotide or vasopressin for bleeding esophageal varices. Ten milligrams of pantoprazole pantoprazole sodium for injection, panto iv, altananycomed, oakville, ontario. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropinreleasing hormone, decreases. Pantoprazole 40 mg, powder for solution for injection. Sandostatin, sandostatin lar depot octreotide injection. Following subq injection, immediaterelease formulation is rapidly and completely absorbed. Patients receiving pantoprazole iv should be converted to po dosing as soon as possible. Physical compatibility of pantoprazole with selected. Iv geriatric patients, debilitated patients, or asa iii iv patients. Extended stability of pantoprazole for injection in 0.
Octreotide is a manmade protein that is similar to a hormone in the body called somatostatin. Octreotide is an analog of somatostatin which can reduce gastrointestinal, biliary, and pancreas secretions, as well as decrease gastrointestinal motility 1. What is octreotide sandostatin, sandostatin lar depot. Each vial contains 40 mg of pantoprazole as sodium sesquihydrate. It was approved for use in the united states in 1988. Protonix pantoprazole dosing, indications, interactions. Side effects and safety information adverse reactions. After a single im injection of the longacting depot dosage form sandostatin lar depot in healthy volunteer subjects, the serum octreotide concentration reached a transient initial peak of about 0. Physical compatibility of pantoprazole with selected medications. It was first synthesized in 1979, by the chemist wilfried bauer. For intravenous injection or intravenous infusion, dilute with sodium chloride 0. Pantoprazole dosing has not been studied in patients with severe hepatic impairment or in those under 18 years of age.
225 41 1377 360 1028 1304 990 138 1287 576 141 355 728 253 84 486 1322 349 702 535 309 19 890 706 206 1388 330 1132 1025 717 1462 803 1119